Enhertu already has seven FDA approvals across breast cancer, gastric cancer, non-small cell lung cancer (NSCLC), and ...

It’s a very uncomfortable time for growth investors, and tech investors, in particular. Tech stocks have traditionally performed well when growth is strong. As the outlook for global growth has ...

The partners are pushing to expand Enhertu’s list of indications beyond its standing uses in breast, lung and gastric cancers ...

Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...

Aliya Omer, VP, US franchise head, breast cancer, AstraZeneca, discusses how results of the trial compare with other treatments for gBRCAm HER2-negative high-risk early breast cancer.

The Aga Khan University Hospital, Nairobi (AKUHN) has secured a $100,000 grant from AstraZeneca to study the impact of nurse navigators in early breast cancer care.

An overwhelming majority of Dutch people have no regrets about being vaccinated against coronavirus during the pandemic, ...

India Cements Ltd recorded volume of 67.31 lakh shares by 14:14 IST on NSE, a 11.95 times surge over two-week average daily volume of 5.63 lakh shares. The stock gained 11.67% to Rs.286.50. Volumes ...

In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

Alex Reid was wrongly advised on early vaccination due to a clinical mistake 17 years earlier. The firm said the decision was taken because of a decline in demand for the vaccine.

GSK, Amgen and AstraZeneca released positive data supporting their rival drugs in a condition called chronic rhinosinusitis ...

"Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP" was originally created and published by ...